Schaeffer's Top Stock Picks for '25

3 Stocks Down Sharply Today

USAT will restate several financial statements

Feb 7, 2019 at 2:58 PM
facebook X logo linkedin


Stocks are staring at stiff losses following fresh U.S.-China trade news. Among individual names making big moves lower are ePort parent USA Technologies, Inc. (NASDAQ:USAT), biotech Sangamo Therapeutics Inc (NASDAQ:SGMO), and diagnostic testing specialist OraSure Technologies, Inc. (NASDAQ:OSUR). Here's a quick look at what's moving the shares of USAT, SGMO, and OSUR.

Sinking USA Technologies at Risk for Bear Notes

USA Technologies stock is trading down 52.9% at $3.24 -- fresh off a three-year low of $3.19 -- after RSM US LLC resigned as auditor of an internal investigation into the electric payments processor. The company's board will also restate financial statements for 2017 and 2018.

The stock is now down 80% from its Aug. 29 13-year high of $16.83, yet bullish analysts have yet to budge. All four covering brokerage firms maintain a "strong buy" rating on USAT, while the average 12-month price target sits all the way up at $9.25. A round of bear notes could exacerbate pressure on the shares.

Options Bulls Target Quick Bounce for Sangamo Therapeutics

Sangamo Therapeutics has plunged to a 21-month low of $6.26 earlier, last seen down 30.8% at $8.32. The company said an experimental gene therapy treatment treatment for Hunter syndrome didn't yield strong data.

The volatile price action has sparked heavy trading in SGMO's options pits, with around 14,000 calls and 8,200 puts on the tape -- six times what's typically seen, and put volume at a new annual high. Most active are the February 10 puts, where it looks like positions are being liquidated. Elsewhere, buy-to-open activity has been detected at the February 8 and 9 calls, which expire at the close next Friday, Feb. 15.

Weak Guidance Levels OraSure Technologies

OraSure Technologies reported better-than-forecast fourth-quarter profit and revenue last night, but the company predicted a surprise current-quarter loss and wider-than-anticipated drop in revenue. Jefferies cut its OSUR price target to $11 from $13.50 -- calling the guidance "alarming" -- with the stock last seen down 24.5% to trade at $9.68, earlier hitting a two-year low of $9.15.

Analysts have been mixed when it comes to OSUR stock. While the three brokerage firms in coverage maintain a lukewarm "hold" rating, the average 12-month price target of $12.67 is a 31.6% premium to the equity's current perch. More price-target cuts could come down the pike if the equity continues to struggle.

 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?